BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14624428)

  • 1. Restenosis due to underexpansion of sirolimus-eluting stent in a bifurcation lesion.
    Takebayashi H; Kobayashi Y; Dangas G; Fujii K; Mintz GS; Stone GW; Moses JW; Leon MB
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):496-9. PubMed ID: 14624428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
    Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
    Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
    [No Abstract]   [Full Text] [Related]  

  • 3. Coexistent in-stent restenosis, late incomplete stent apposition and mural thrombus in a zotarolimus-eluting stent.
    Zhang F; Qian J; Ge J
    J Invasive Cardiol; 2008 Aug; 20(8):423-5. PubMed ID: 18688068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
    Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW
    Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
    Kastrati A; Dibra A; Mehilli J; Mayer S; Pinieck S; Pache J; Dirschinger J; Schömig A
    Circulation; 2006 May; 113(19):2293-300. PubMed ID: 16682614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement.
    Neumann FJ; Desmet W; Grube E; Brachmann J; Presbitero P; Rubartelli P; Mügge A; Di Pede F; Füllgraf D; Aengevaeren W; Spedicato L; Popma JJ
    Circulation; 2005 Apr; 111(16):2107-11. PubMed ID: 15851617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary stent fracture and restenosis in the drug-eluting stent era: do we have clues of management?
    Kim EJ; Rha SW; Wani SP; Suh SY; Choi CU; Kim JW; Park CG; Seo HS; Oh DJ
    Int J Cardiol; 2007 Sep; 120(3):417-9. PubMed ID: 17084924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent.
    Wessely R; Pache J; Schömig A
    Transpl Int; 2005 Sep; 18(9):1113-5. PubMed ID: 16101733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed strut fracture of sirolimus-eluting stent: a significant problem or an occasional observation?
    Min PK; Yoon YW; Moon Kwon H
    Int J Cardiol; 2006 Jan; 106(3):404-6. PubMed ID: 16337054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary restenosis after implantation of drug-eluting stents.
    Schofer J; Schlüter M
    Minerva Cardioangiol; 2005 Feb; 53(1):43-8. PubMed ID: 15788978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
    Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
    J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stent fracture and restenosis in the drug-eluting stent era.
    Sianos G; Hofma S; Ligthart JM; Saia F; Hoye A; Lemos PA; Serruys PW
    Catheter Cardiovasc Interv; 2004 Jan; 61(1):111-6. PubMed ID: 14696169
    [No Abstract]   [Full Text] [Related]  

  • 14. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
    Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
    Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of sirolimus-eluting stents in diabetics with complex coronary lesions].
    Berenguer A; Mainar V; Bordes P; Valencia J; Gómez S
    Rev Esp Cardiol; 2006 Feb; 59(2):117-24. PubMed ID: 16540032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
    Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
    Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
    Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus, Tacrolimus and Zotarolimus eluting stents to treat bifurcated lesions: a 7-month clinical outcome comparison.
    Brugaletta S; Burzotta F; Trani C; Todaro D; Talarico G; Porto I; Leone AM; Niccoli G; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Minerva Cardioangiol; 2008 Feb; 56(1):35-42. PubMed ID: 18432167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy.
    Pan M; de Lezo JS; Medina A; Romero M; Segura J; Pavlovic D; Delgado A; Ojeda S; Melián F; Herrador J; Ureña I; Burgos L
    Am Heart J; 2004 Nov; 148(5):857-64. PubMed ID: 15523318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.